Curepharma SRL
1.6 FTECurepharma reported total assets of 516,103 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Aug 2026), with 1.6 full-time equivalent.
The score of Curepharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -23 % Total assets -14 % Headcount (avg FTE) +14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Curepharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −63,131 € | ||||
| Equity | 355,161 € | ||||
| Cash | 166,420 € | ||||
| EBITDA | −44,610 € | ||||
| Total assets | 516,103 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Aug 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
Curepharma's financial analysis
- Solvency68.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Curepharma
Curepharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0425.132.687
- VAT number
- BE0425132687
- Peppol
- Registered · 0208:0425132687 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Dec 1983
- Registered office
- 2020 Antwerp
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 18 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Curepharma (SRL) has been based in Antwerp since 1983, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 63,131 € and equity of 355,161 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 68.8%, above the median of its sector (44.2%).
Companies similar to Curepharma
Companies in the same business, of comparable size and area, outside its group.
- Flowers Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 516,128 €
- Apotheek Candide Jacobs Retail sale of pharmaceutical products De Haan · balance sheet 515,835 €
- Almapharma Retail sale of pharmaceutical products De Panne · balance sheet 515,565 €
- Phaies Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 516,859 €
- La Pharmacie de Saintes Retail sale of pharmaceutical products Tubize · balance sheet 514,575 €
- Milliemo Retail sale of pharmaceutical products Lochristi · balance sheet 519,776 €
- Pharmatheek Retail sale of pharmaceutical products Drogenbos · balance sheet 520,106 €
- Wezel Pharma Retail sale of pharmaceutical products Mol · balance sheet 520,638 €
Frequently asked questions about Curepharma
What is the revenue of Curepharma?
Curepharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Curepharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0425132687 for Curepharma, if the company is VAT-registered. Its company number (CBE) is 0425.132.687.
Where is the registered office of Curepharma?
According to the CBE register, the registered office of Curepharma is in 2020 Antwerp.
What is the equity of Curepharma?
At the close of the 2025 financial year, the equity of Curepharma amounts to 355,161 €, a solvency of 68.8% of total assets.
How many people work at Curepharma?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Curepharma?
The register lists 2 active mandates at Curepharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Curepharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →